MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.

ABSTRACT:

Background

Heritable factors are evidently involved in prostate cancer (PrCa) carcinogenesis, but currently, genetic markers are not routinely used in screening or diagnostics of the disease. More precise information is needed for making treatment decisions to distinguish aggressive cases from indolent disease, for which heritable factors could be a useful tool. The genetic makeup of PrCa has only recently begun to be unravelled through large-scale genome-wide association studies (GWAS). The thus far identified Single Nucleotide Polymorphisms (SNPs) explain, however, only a fraction of familial clustering. Moreover, the known risk SNPs are not associated with the clinical outcome of the disease, such as aggressive or metastasised disease, and therefore cannot be used to predict the

SUBMITTER: Fischer D 

PROVIDER: S-EPMC4447459 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature